Ubrolexin

Broad Spectrum Intramammary Treatment for Clinical Mastitis

Composition

Each 10g Intramammary syringe contains Cefalexin (as monohydrate)- 200mg, Kanamycin ( as monosulphate)-100000 IU

Indication/ Recommendation

Treatment of Clinical Mastitis in lactating cows caused by bacteria susceptible to the combination of Cefalexen & Kanamycin such has Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis, E.coli & CNS

Dosage & Administration

Treat the infected quarter’s with 1 syringe/udder quarter for 2 consecutive days at 24 hours interval

Presentation

Box of 20 Tubes with teat wipes